Comparison of Popular Research Peptides (2026)
Research Peptide Comparison: IGF-1 DES, TB-4 and More
Research peptides are short amino-acid sequences or peptide-derived materials examined across many different biochemical and cell-model contexts. Sharing the label “peptide” does not make two compounds interchangeable: sequence, molecular size, modification, target interaction and analytical format can all differ substantially.
This guide compares terminology and research classification for several frequently discussed materials, including IGF-1 DES and TB-4/TB-500. It describes rather than recommends. It does not provide dosage, administration, stacking or human-use guidance.
How to compare research peptides responsibly
A useful comparison starts with molecular identity rather than a promised outcome. Researchers should distinguish the complete name, amino-acid sequence or analogue designation, molecular format, batch documentation and model used in the relevant literature.
| Research term | Identity or classification | Neutral research context |
|---|---|---|
| IGF-1 DES | Truncated analogue of IGF-I, also written des(1-3)IGF-I | Binding-protein interaction, receptor binding and cell-signalling models |
| TB-4 | Common shorthand for thymosin beta-4 | Actin binding, cytoskeletal organisation and related biochemical models |
| TB-500 | Commercial research-material term associated with thymosin beta-4 discussion | Material identity and fragment/full-length distinctions require verification |
| Ipamorelin | Synthetic peptide examined for growth-hormone-secretagogue receptor interaction | Receptor selectivity and neuroendocrine-signalling models |
| CJC-1295 | Synthetic GHRH-related analogue; DAC and no-DAC forms are distinct | Analogue structure, binding and signalling-duration research |
| BPC-157 | Synthetic peptide sequence discussed in experimental literature | Cell, tissue and signalling models; evidence remains model-dependent |
The listed research contexts are descriptive only. They do not establish clinical efficacy, safety or suitability for human use.
IGF-1 DES: a defined truncated analogue
IGF-1 DES is also described as des(1-3)IGF-I or des-(1-3)-IGF-I. The name identifies an analogue lacking the first three amino acids at the N-terminus of IGF-I. That structural definition is important because shorthand references to “IGF” do not distinguish native IGF-I from truncated or extended analogues.
Laboratory literature has examined IGF-1 DES in binding-protein, receptor-binding and cell-signalling models. Interpretation depends on the cell type, assay conditions and binding proteins present. Findings from an in-vitro or animal model should not be presented as an expected human outcome.
Review the full IGF-1 DES product identity and research context and the available Lab Analysis and COA information.
TB-4 and TB-500: associated names, not automatic equivalents
TB-4 is commonly used as shorthand for thymosin beta-4 (Tβ4), an endogenous beta-thymosin protein examined in actin-binding and cytoskeletal research. TB-500 is a commercial research-material term frequently associated with thymosin beta-4 discussion.
The commercial name alone does not prove that a material is full-length thymosin beta-4. One analytical publication identified an acetylated thymosin beta-4 fragment in a TB-500-labelled material. Full-length proteins, fragments and modified derivatives can differ in sequence, molecular mass and analytical behaviour, so conclusions should remain tied to the exact preparation studied.
NutriMax lists different TB-500-associated formats, including TB-500 research tablets and a TB-500 research pen. Product format does not establish molecular equivalence or an expected result.
Why sequence, fragments and modifications matter
A single amino-acid substitution, deletion or terminal modification can change mass, charge, conformation, analytical retention and interaction characteristics. Terms such as analogue, fragment, conjugate, acetylated and amidated therefore carry meaningful structural information.
Researchers should avoid transferring evidence between similarly named materials unless identity and preparation are genuinely comparable. The exact molecular description in a publication should take priority over a commercial shorthand term.
Peptide format and bundled laboratory materials
Listings may describe lyophilised material, tablets, prepared research formats or bundles that include an additional laboratory material such as bacteriostatic water. The nominal quantity should be read carefully: a bundled price or product title may refer to more than the peptide alone.
Format does not by itself establish purity, identity, stability or suitability for a method. Any supplied liquid, pen, vial or bundled material should be assessed against the purchaser’s own laboratory protocol and documentation requirements.
Reading purity and identity information
High-performance liquid chromatography can describe a chromatographic purity profile under stated conditions, while mass spectrometry can support molecular-mass identification. These methods are complementary, but neither result alone establishes every attribute of a preparation.
Review the Peptide Purity and Testing Standards guide. Researchers should distinguish identity, purity, content, stability and sterility rather than treating one percentage as a complete quality assessment.
Related peptide research resources
- What Are Peptides? Structure, Types and Research
- How Peptides Are Studied in Labs
- Peptide Purity and Testing Standards
- Research peptide collection
- Global Legality Guide
Frequently asked questions
Are all research peptides comparable?
No. Peptide is a broad structural category. Sequence, length, modification, preparation and research context may differ.
Is TB-500 identical to thymosin beta-4?
The names are commonly associated, but exact identity should be confirmed from the specification and analytical documentation rather than assumed from the shorthand label.
What is IGF-1 DES?
IGF-1 DES is a truncated IGF-I analogue lacking the first three N-terminal amino acids. It should be distinguished from native IGF-I and other analogues.
Does a purity percentage prove identity?
No. Purity and identity are related but distinct analytical questions. The method, reference standard and other documentation should be reviewed.
Does NutriMax PES provide human-use guidance?
No. NutriMax PES does not provide dosage, cycle, administration, stacking or human-use guidance.
Selected references
- Thymosin beta-4 and actin polymerisation in living-cell models
- Thymosin beta-4, F-actin cycling and cell-migration models
- Analytical identification of a thymosin beta-4 fragment in a TB-500-labelled material
Supplied for research purposes only. Not for human or veterinary use. This information is educational and does not constitute medical advice.